Log in

Relevant bibliographies by topics / Beta-lactam antibiotics

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Beta-lactam antibiotics'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Beta-lactam antibiotics.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Beta-lactam antibiotics"

1

Oates, John A., Alastair J. J. Wood, Gerald R. Donowitz, and Gerald L. Mandell. "Beta-Lactam Antibiotics." New England Journal of Medicine 318, no. 7 (1988): 419–26. http://dx.doi.org/10.1056/nejm198802183180706.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Oates, John A., Alastair J. J. Wood, Gerald R. Donowitz, and Gerald L. Mandell. "Beta-Lactam Antibiotics." New England Journal of Medicine 318, no. 8 (1988): 490–500. http://dx.doi.org/10.1056/nejm198802253180806.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Asham, Preet Saini1 Shivam Sharma2 Tarun Sharma3 Kailash Singh Bisht*4. "Evaluation And Management Strategies for Beta-Lactam Antibiotics Induced Hypersensitivity Reactions: A Comprehensive Review." International Journal of Pharmaceutical Sciences 3, no. 3 (2025): 3188–206. https://doi.org/10.5281/zenodo.15110977.

Full text

Abstract:

Beta-lactam antibiotics are essential and extensively utilized medications for bacterial infections in clinical settings. Penicillin has the highest prevalence of inducing hypersensitivity reactions among beta-lactam antibiotics. This can lead to poor treatment outcomes, increased risk for antibiotic resistance, and high treatment expenses. With an increasing number of suspected cases of hypersensitivity reactions, it is essential to accurately diagnose them using sensitive skin testing and in-vitro methods, while minimizing the risk of serious adverse reactions. A thorough evaluation could ef

APA, Harvard, Vancouver, ISO, and other styles

4

Bradley, Nicole, Yuman Lee, and Dana Weinstein. "Overview of Beta-Lactam Allergy and the Role of the Pharmacist in Management." Allergies 1, no. 2 (2021): 128–36. http://dx.doi.org/10.3390/allergies1020011.

Full text

Abstract:

Unverified beta-lactam allergies are a substantial public health problem, as the majority of patients labeled as beta-lactam allergic do not have clinically significant allergies that may hinder the use beta-lactam therapy when indicated. Outdated or inaccurate beta-lactam or penicillin allergies can result in serious consequences, including suboptimal antibiotic therapy, increased risk of adverse effects, and use of broader spectrum antibiotics than indicated, which may contribute to antimicrobial resistance. The purpose of this review is to provide an overview of beta-lactam allergy and high

APA, Harvard, Vancouver, ISO, and other styles

5

BALDWIN, JACK E., GREGORY P. LYNCH, and JANOS PITLIK. ".GAMMA.-Lactam analogues of .BETA.-lactam antibiotics." Journal of Antibiotics 44, no. 1 (1991): 1–24. http://dx.doi.org/10.7164/antibiotics.44.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ji, Youqi, Yinhuan Wang, Zhangkai Xu та ін. "Small Molecules from Medicinal Plant Iris tectorum as Histidine Kinase Inhibitor to Resensitize β-Lactam-Resistant Escherichia coli". Molecules 30, № 3 (2025): 663. https://doi.org/10.3390/molecules30030663.

Full text

Abstract:

Background: Due to the widespread use of broad-spectrum antibiotics, the problem of antibiotic resistance has become an increasingly serious global threat. One of the key mechanisms of Escherichia coli resistance to beta-lactam antibiotics is the production of beta-lactamase enzymes, which poses a dilemma for clinicians in selecting antibiotics when faced with resistant bacterial infections. However, research on the reversal of bacterial resistance is limited. Methods: This study involved the preparation of Iris tectorum extract and detection of its effects on antibiotics sensitivity, extended

APA, Harvard, Vancouver, ISO, and other styles

7

Chandrasekar, Pranatharthi H., and George J. Alangaden. "Newer beta-lactam antibiotics." Current Opinion in Infectious Diseases 9, no. 6 (1996): 391–97. http://dx.doi.org/10.1097/00001432-199612000-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Semizhon, P. A., H. P. Scheslenok, I. V. Harbachova, I. I. Vashkevich, and O. V. Sviridov. "MONITORING OF BIOLOGICAL ACTIVITY OF BETA-LACTAM ANTIBIOTICS RECEPTOR BLAR-CTD IN THE PROCESSES OF ITS HETEROLOGICAL EXPRESSION, PURIFICATION AND APPLICATION IN ANALYTICAL SYSTEMS." http://eng.biomos.ru/conference/articles.htm 1, no. 19 (2021): 246–48. http://dx.doi.org/10.37747/2312-640x-2021-19-246-248.

Full text

Abstract:

To develop the technologies of beta-lactam antibiotics bioassays in foods, high purity beta-lactam receptor BlaR-CTD has been obtained and characterized. A test system for the quantitation of the biologically active and immunoreactive receptor in the processes of its heterological expression, isolation and reagent forms preparation was elaborated. The immunochemical properties and antibiotic binding ability of BlaR-CTD were investigated, and the constructions and application procedures of receptor-immune systems for the assay of beta-lactam antibiotics using microplates or chromatographic test

APA, Harvard, Vancouver, ISO, and other styles

9

Mukhsinov, Farkhod Munisovich, and Irina Vladimirovna Liverko. "PHENOTYPIC PREDICTORS AND BIOMARKERS FOR FORECASTING THE EFFECTIVENESS OF ANTIMICROBIAL THERAPY." journal of cardiorespiratory research 3, no. 3 (2022): 3. https://doi.org/10.5281/zenodo.7145906.

Full text

Abstract:

According to the results, it was found that the serum beta-lactamase activity level is determined by phenotypic and clinical variables: age over 60 years, severe respiratory pathology, fever over 380 , peripheral blood leukocyte level over 10x109, C-reactive protein over 40 mg/L and saturation less than 93%, correlating with an increase in UAV levels, and are predictors of low efficacy of treatment with beta-lactam antibiotics. A direct correlation was revealed between the level of serum beta-lactamase activity and the duration of antimicrobial therapy during the year (r=+0.86, p=0.001), the n

APA, Harvard, Vancouver, ISO, and other styles

10

Asada, K., Y. Inaba, E. Tateda-Suzuki, K. Kuwahara-Arai, T. Ito, and K. Hiramatsu. "Evolution and resistance expression of MRSA. Evaluation of beta-lactam antibiotics against a set of isogenic strains with different types of phenotypic expression." Acta Biochimica Polonica 42, no. 4 (1995): 517–24. http://dx.doi.org/10.18388/abp.1995_4905.

Full text

Abstract:

Methicillin-resistant Staphylococcus aureus (MRSA) has two mechanisms of resistance to beta-lactam antibiotics; one is mediated by mecA gene expression, and the other by penicillinase production. It has been generally accepted in the clinical field that beta-lactam antibiotics are not the drugs of choice for MRSA infection. In this report, however, ampicillin and penicillin G were shown to have relatively good activity against MRSA if combined with a beta-lactamase inhibitor, sulbactam. These beta-lactam antibiotics were found to have relatively high binding affinities to PBP2', the mecA-encod

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Beta-lactam antibiotics"

1

Cuthbert, B. K. "Analogues of beta-lactam antibiotics." Thesis, University of Oxford, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.370245.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Rogers, M. E. "Beta-lactam antibiotics : Analysis and biosynthesis." Thesis, University of Westminster, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.383031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Vasilenko, Sofia, and Софія Василенко. "Bacteria resistance to beta-lactam antibiotics." Thesis, National Aviation University, 2021. https://er.nau.edu.ua/handle/NAU/50637.

Full text

Abstract:

1. Pulok K. Mukherjee. Quality Control and Evaluation of Herbal Drugs: Evaluating Natural Products and Traditional Medicine. Elsevier, 2019. 762 p. 2. Kumar A., Schweizer H. Bacterial resistance to antibiotics: Active efflux and reduced uptake. Adv. Drug Deliv. Rev. 2005. Vol. 57. P. 513. 3. Antimicrobial Resistance: Tackling a Crisis for the Future Health and Wealth of Nations. Chaired by Jim O’Neill. London: Review on Antimicrobial Resistance. 2014. 16 p. 4. Thomas C. M., Nielsen K.M. Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nat. Rev. Microbiol. 2005. Vol. 3

APA, Harvard, Vancouver, ISO, and other styles

4

Hadfield, Peter Stanley. "The synthesis of #gamma#-lactam mimics of #beta#-lactam antibiotics." Thesis, University of Huddersfield, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.338614.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Jayaweera, G. D. S. A. "Some aspects of beta-lactam chemistry." Thesis, University of Newcastle Upon Tyne, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.370619.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Hedberg, Maria. "[Beta]-lactam resistance in anaerobic bacteria." Stockholm : Division of Oral Microbiology, Dept. of Immunology, Microbiology, Pathology and Infectious Diseases, Hudding University Hospital, Karolinska Institute, 1995. http://catalog.hathitrust.org/api/volumes/oclc/33394040.html.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Schofield, C. "Chemical and enzymatic synthesis of beta-lactam antibiotics." Thesis, University of Oxford, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.355775.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Freeman, Richard Neil Templar. "The total synthesis of non-beta-lactam antibiotics." Thesis, University of Oxford, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.257963.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Blackburn, Jonathan Michael. "Investigation into the biosynthesis of #beta#-lactam antibiotics." Thesis, University of Oxford, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.303654.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bolister, Nina Jane. "The diffusion of beta-lactam antibiotics through biopolymers." Thesis, University of Brighton, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.328209.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Beta-lactam antibiotics"

1

F, Queener Sherry, Webber J. Alan 1940-, and Queener Stephen W, eds. Beta-lactam antibiotics for clinical use. M. Dekker, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

M, Livermore D., ed. The Clinical importance of beta-lactam resistance. Vieweg, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Susumu, Mitsuhashi, and Franceschi G, eds. Penem antibiotics: FCE 22101 and its orally absorbed ester FCE 22891. Japan Scientific Societies Press, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bolister, Nina Jane. The diffusion of beta-lactam antibiotics through biopolymers. Brighton Polytechnic Department ofPharmacy, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Alle, Bruggink, ed. Synthesis of [beta]-lactam antibiotics: Chemistry, biocatalysis & process integration. Kluwer Academic Publishers, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bellido, F. The new -lactams: Mode of action, mechanisms of resistance. Roche, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hamao, Umezawa, Takeda Kagaku Shinkō Zaidan, and Takeda Science Foundation Symposium (4th : 1986 : Kyoto, Japan), eds. Frontiers of antibiotic research. Academic Press, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kawamoto, Isao. Antibiotics I: [beta]-lactams and other antimicrobial agents. Gordon and Breach Science Publishers, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Washington, John A. The role of beta-lactamases in microbial resistance to beta-lactam antibiotics. Upjohn, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Gangwer, Michael I. On-farm screening tests for beta-lactam residues in milk. Oregon State University Extension Service, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Beta-lactam antibiotics"

1

Danziger, Larry H., and Melinda Neuhauser. "Beta-Lactam Antibiotics." In Drug Interactions in Infectious Diseases. Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-213-7_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Danziger, Larry H., and Karolyn S. Horn. "Beta-Lactam Antibiotics." In Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72416-4_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Cojocel, Constantin. "Beta-lactam antibiotics." In Clinical Nephrotoxins. Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-84843-3_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Neuhauser, Melinda M., and Larry H. Danziger. "Beta-Lactam Antibiotics." In Drug Interactions in Infectious Diseases. Humana Press, 2001. http://dx.doi.org/10.1007/978-1-59259-025-4_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bhandari, Prasan. "Beta-lactam antibiotics." In Pharmacology Mind Maps for Medical Students and Allied Health Professionals. CRC Press, 2019. http://dx.doi.org/10.1201/9780429023859-57.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Page, Malcolm G. P. "Beta-Lactam Antibiotics." In Antibiotic Discovery and Development. Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-1400-1_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Cojocel, Constantin. "Beta-lactam antibiotics." In Clinical Nephrotoxins. Springer Netherlands, 2003. http://dx.doi.org/10.1007/1-4020-2586-6_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Barredo, José-Luis, Gulay Ozcengiz, and Arnold L. Demain. "Advances in Beta-Lactam Antibiotics." In Antimicrobial Compounds. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-40444-3_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Muller, Anouk E., and Johan W. Mouton. "Continuous Infusion of Beta-lactam Antibiotics." In Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics. Springer New York, 2013. http://dx.doi.org/10.1007/978-0-387-75613-4_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tune, Bruce M., and Chieh-Yin Hsu. "Prevention of nephrotoxicity of beta-lactam antibiotics." In Prevention in nephrology. Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3798-0_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Beta-lactam antibiotics"

1

Islam, Zainul, Septianita Hastuti, and Nadya Firstiana. "Analysis of Cost Effectiveness of Beta–Lactam Antibiotics in Child Pneumonia Patients." In Proceedings of the 1st International Conference on Economic and Education, ICON 2021, 14 - 15 December 2021, Padang-West Sumatra, Indonesia. EAI, 2022. http://dx.doi.org/10.4108/eai.14-12-2021.2318538.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Luo, Qijian, and Yiqi JIn. "Oral Beta-lactamase Protects the Gut Bifidobacterium/Lactobacillus from Beta-lactam Antibiotics-mediated Damage in SD Rats." In ICBBS '20: 2020 9th International Conference on Bioinformatics and Biomedical Science. ACM, 2020. http://dx.doi.org/10.1145/3431943.3431948.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Núñez-Núñez, M., R. Morón-Romero, R. Álvarez-Sánchez, et al. "4CPS-048 Beta-lactam antibiotics in critical ill patients: are we dosing our patients correctly?" In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Horn, M., S. Micek, and M. H. Kollef. "Use of Beta-lactam Antibiotics in the Management of Sepsis in the Intensive Care Unit." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3434.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Pareek, Chandresh. "An Efficient Combinatorial Approach for Beta-Lactam Antibiotics with Novel Adjuvants against Gram-Negative Organisms to Combat Multi-Drug Resistance." In International conference on Applied Research in Engineering, Science and Technology. ACAVENT, 2018. http://dx.doi.org/10.33422/icarest.2018.09.47.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Torgunakova, Ekaterina Sergeevna, Elena Nikolaevna Bochanova, Irina Vladimirovna Demko, Angelina Yur'Evna Kraposhina, and Evgeniya Mikhailovna Kurts. "Active monitoring of adverse drug reactions to the use of beta-lactam antibiotics in the treatment of community-acquired pneumonia." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.1781.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lopez-Cabezas, C., P. Clares, G. Gotor, et al. "3PC-008 Physicochemical stability of five beta-lactam antibiotics under simulated real-life conditions in outpatient parenteral antimicrobial therapy (OPAT)." In 29th EAHP Congress, Copenhagen, Denmark, 12-13-14 March 2025, Person centred pharmacy — Navigating digital health. British Medical Journal Publishing Group, 2025. https://doi.org/10.1136/ejhpharm-2025-eahp.42.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Muntyan, Victoria S., Mariia E. Vladimirova, Alexey M. Afonin, Alexey N. Muntyan, and Marina L. Roumiantseva. "ANALYSIS OF SALT-SENSITIVE AND SALT-TOLERANT SINORHIZOBIUM MELILOTI STRAINS USING DNA MICROARRAY, PHENOTYPE MICROARRAY AND GENOME MINING TECHNIQUES." In 23rd SGEM International Multidisciplinary Scientific GeoConference 2023. STEF92 Technology, 2023. http://dx.doi.org/10.5593/sgem2023/6.1/s25.15.

Full text

Abstract:

Nodule bacteria increase the resistance of host plants to abiotic stress factors; however, the role of the genetic potential of rhizobia in the formation of productive salt-tolerant plant-microbial symbiosis remains underestimated. The aim of the study was to evaluate the pool of genes responsible for the salt tolerance of the alfalfa microsymbiont, Sinorhizobium meliloti, using the DNA microarray technique, phenotype microarray (PM), NGS and NNGS-technologies and genome mining (antismash 5.0). As a result of the analysis of the genomes of strains contrastingly different in salt tolerance, it

APA, Harvard, Vancouver, ISO, and other styles

9

Đekić-Malbaša, Jelena, Tomi Kovačević, Branislav Tušek, Dunja Tušek, and Ana Milenković. "Clostridioides difficile infections in hospitalized lung diseases patients." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24117d.

Full text

Abstract:

Background: Clostridioides difficile infection (CDI), one of the most common healthcare-associated (HCA) infections, primarily affect the elderly and immune-compromised patients following antimicrobial consumption. Methods and Objectives: The aim was to determine the HCA CDI incidence trend, characteristics of patients, and classes of previously used antibiotics in the Institute for Pulmonary Diseases of Vojvodina (IPBV) from 2015 to 2023. The incidence of HCA CDI was calculated per 1,000 hospital admissions. Retrospective analysis of demographic and clinical characteristics of HCA CDI patient

APA, Harvard, Vancouver, ISO, and other styles

10

Al – Rubaye, Talib, Samia Mahamoud, Aida Ibrahim, and Dalal AL-Rubaye. "Phenotypic and Genotypic Screening of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Isolated from a Sample of Patients with Community-Acquired Urinary Tract Infection." In 5th International Conference on Biomedical and Health Sciences. Cihan University-Erbil, 2024. http://dx.doi.org/10.24086/biohs2024/paper.1336.

Full text

Abstract:

The bacteria Escherichia coli is the most common community-acquired urinary tract infection (UTI) pathogen, which is responsible for 75%–95% of cases, and due to the extensive use of β-lactam antibiotics in clinical cases, Extended- spectrum beta-lactamase (ESBLs) producing Escherichia coli have emerged. This study was done to isolate and identify Escherichia coli in a sample of Iraqi patients with a community- acquired urinary tract infection (CA-UTIs), the ESBL-producing E. coli was characterized phenotypically and genotypically. About 120 urine samples were collected from September 2022 to

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Beta-lactam antibiotics"

1

Chiu, Chia-Yu, and Amara Sarwal. Impact of area under the curve-based vancomycin dosing combination with anti-pseudomonal beta-lactam antibiotics: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0025.

Full text

Abstract:

Review question / Objective: Did AUC-based vancomycin dosing reduce acute kidney injury than trough-based dosing when combined with anti-pseudomonal beta-lactam antibiotic? Condition being studied: Patients received Vancomycin combined with anti-pseudomonal beta-lactam antibiotics and monitor with either trough-base dosing or AUC-based dosing vancomycin. Information sources: All study types except case reports, case series, and conference abstracts were considered. PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched from inception to November2022.

APA, Harvard, Vancouver, ISO, and other styles

2

Dou, Q. P. Synthetic Beta-Lactam Antibiotics as a Selective Breast Cancer Cell Apoptosis Inducer: Significance in Breast Cancer Prevention and Treatment. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada572620.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!